Filing Details
- Accession Number:
- 0001209191-11-044522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-16 18:55:57
- Reporting Period:
- 2011-08-15
- Filing Date:
- 2011-08-16
- Accepted Time:
- 2011-08-16 18:55:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1051411 | T Erle Mast | C/O Somaxon Pharmaceuticals, Inc. 3570 Carmel Mountain Road, Suite 100 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-08-15 | 5,000 | $1.11 | 26,630 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale of shares of common stock underlying vested restricted stock units was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.